Navigation Links
First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting
Date:12/7/2008

ment Inhibitor Eculizumab in a Patient with Cold Agglutinin Disease" was presented today at the ASH annual meeting by Dr. Alexander Roeth of the Department of Hematology at the University Hospital of Essen in Essen, Germany.

Dr. Roeth and his colleagues investigated the potential effect of eculizumab therapy in one patient with CAD, a rare and severe disease characterized by the production of circulatory cold agglutinins, a type of monoclonal antibody that lead to hemolysis. Conventional treatments for CAD, including corticosteroids and immunosuppressive drugs, are ineffective in many patients.

"We currently lack effective treatment options for patients with CAD," noted Dr. Roeth. "Given these promising initial observations, clinical research is needed to determine the therapeutic potential of eculizumab in patients with CAD."

About Soliris

Soliris was approved in March 2007 by the U.S. Food and Drug Administration (FDA) as the first treatment for PNH, a rare, debilitating and life-threatening blood disorder defined by hemolysis, or the destruction of red blood cells. In June 2007, the European Commission (EC) also approved the use of Soliris for the treatment of patients with PNH. Soliris is the first therapy approved in Europe for the treatment of PNH and was the first medicinal product to receive EC approval under the EMEA Accelerated Assessment Procedure. Soliris is not approved for the treatment of atypical Hemolytic Uremic Syndrome (aHUS) and Cold Agglutinin Disease (CAD).

Important Safety Information

Soliris is generally well tolerated. The most frequent adverse events observed in clinical studies were headache, nasopharyngitis (a runny nose), back pain and nausea. Treatment with Soliris should not alter anticoagulant management because the effect of withdrawal of anticoagulant therapy during Soliris treatment has not been established.

The
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease
2. FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
3. Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351
4. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
5. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
6. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
7. Zevalin(R) Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkins Lymphoma
8. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
9. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
10. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
11. First Town Hall Meeting on Inequities in Clinical Trials to Take Place at the Harlem Hospital Center on October 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... the development and commercialization of a once-daily, oral ... cholesterol gallstones, today announced that it has appointed ... Clinical Operations. Mr. Tonelli brings 20+ ... and regulatory affairs.  From 2005 to 2014, Mr. ...
(Date:4/1/2015)... Columbia and MENLO PARK, Calif. ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), ... Erich Mohr , Ph.D., R.Psych., to its Board ... Mohr has close to two decades of biotechnology experience ... chief executive officer and board member, including serving as ...
(Date:4/1/2015)... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... of the tender offer (the "Offer") by a subsidiary ... the outstanding shares of Salix Pharmaceuticals, Ltd. (NASDAQ: ... share in cash, without interest, less any applicable withholding ... April 1, 2015.  Valeant expects to complete today the ...
Breaking Medicine Technology:Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations 2Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations 3DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 2DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 3DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 4Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd. 2Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd. 3
... 2011 Cytta Corp (OTCQB: CYCA) is pleased to ... client installation and deployment of our remote medical monitoring ... full scale roll out of its technology, concentrating initially ... as: Health Plans, Managed Care Organizations, Health Delivery Organizations, ...
... .decimal, Inc. (pronounced dot decimal), an innovative manufacturer of ... received 510(k) clearance from the FDA to market electron ... are now available to radiation oncology centers across the ... also known as electron ,cutouts, by radiation therapy departments ...
Cached Medicine Technology:First Client Installation of CyttaConnect™ Medical Monitoring System 2First Client Installation of CyttaConnect™ Medical Monitoring System 3Florida Medical Device Manufacturer Announces New Product Release for Radiation Therapy 2
(Date:4/1/2015)... (PRWEB) April 01, 2015 SkillSurvey, the ... in the talent lifecycle, and the premiere provider of ... Series will feature a webinar on “Using Big Data ... the chief human resources officer of MorseLife, a nationally ... for seniors and their families in Palm Beach County. ...
(Date:4/1/2015)... 01, 2015 Skin cancer is one of ... if caught early. Forefront Dermatology and Dermatology Associates of Wisconsin ... condition before it spreads so they are hosting a free ... from 8:30am - 12:30pm. , “If we can see ... of concern, that could become cancerous,” said Dr. Ken Katz, ...
(Date:4/1/2015)... 2015 It is the meat that has ... now found wrapped around other foods, infused into cocktails and ... meat candy, the gateway meat for vegetarians and the perfect ... North American Meat Institute (NAMI) has developed a new ... of a bacon processing plant and companion brochure ...
(Date:4/1/2015)... 01, 2015 Nike Tennis Camps will ... and girls ages 10-17, providing campers with the opportunity ... will experience all 4 Grand Slam surfaces on 22 ... of Great Britain’s Davis Cup team and national governing ... Richmond Park, the National Tennis Centre is the perfect ...
(Date:4/1/2015)... UT (PRWEB) April 01, 2015 Pricing Healthcare ... the last several months, bring coverage to a third of ... the states of Massachusetts, Kansas, and Iowa, and the first dedicated ... imaging center in Dallas, TX was also added. , In addition, ... Traffic to and general interest in the platform continue to grow ...
Breaking Medicine News(10 mins):Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 3Health News:Forefront Dermatology and Dermatology Associates of Wisconsin Offers Skin Cancer Screenings on April 11th 2Health News:New Ultimate Guide to Bacon Video Provides Inside Look at How Bacon is Made 2Health News:US Sports Camps and Nike Tennis Camps to Launch in London, England this Summer 2Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 2Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 3
... health problems outside the lungs, researchers say , , WEDNESDAY, ... and long-term toxic effects on the heart and blood ... cause death, a new report says. , The ... issue of the Journal of the American College ...
... Physician Accuracy And ... Reduces Radiation Exposure for Patients, AUSTIN, Texas, Aug. ... Institute (TCAI) at St. David,s Medical Center became,the first ... -- an enhancement to the state-of-the art Hansen Robotic ...
... ("Assurant"),(NYSE: AIZ ), a premier provider of ... that Jane Meyer,has been appointed senior vice president, ... vice president, organizational development and,corporate communications effective immediately. ... and Mr. Walker will continue to report to ...
... Daily Dietary Supplements to Introduce Fashion Week ... Survival Kit at Verrier Runway Show, ... its,first-ever fashion partnership with breakout designer Ashleigh Verrier to,promote "Style ... healthy beauty during one of the most exciting and fast-paced,fashion ...
... the National Institutes of Health (NIH) have found a mechanism ... the development of autoimmune disease when turned off. The findings ... of autoimmunity and could also have implications for the development ... as cancer and HIV. The study paper appears online today ...
... strength, agility tied to brain damage, even in the ... -- Physical frailty among the elderly may be linked ... patients develop dementia, new research reveals. , The finding, ... the notion that motor impairment in the elderly is ...
Cached Medicine News:Health News:Air Pollution Can Damage Heart, Blood Vessels, Too 2Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in the Nation to Use a New Generation of Medical Robots for Complex Electrophysiology Mapping Procedures 2Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in the Nation to Use a New Generation of Medical Robots for Complex Electrophysiology Mapping Procedures 3Health News:Assurant Announces Two Executive Appointments 2Health News:VIACTIV(R) Partners With Rising Fashion Label Verrier to Launch 'Style and Strength for Life' Health Initiative at Fall Fashion Week 2008 2Health News:VIACTIV(R) Partners With Rising Fashion Label Verrier to Launch 'Style and Strength for Life' Health Initiative at Fall Fashion Week 2008 3Health News:NIH scientists find a novel mechanism that controls the development of autoimmunity 2Health News:Physical Frailty Could Predict Alzheimer's Disease 2Health News:Physical Frailty Could Predict Alzheimer's Disease 3
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTP/1Q-PAL chairs are recommended for ... clean room, static control, health care ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With polished ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With polished ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
Medicine Products: